Evidence map›Paper›PMID 39565920›Full record

ArticleJournal of the National Cancer Institute2025

The association of where patients with prostate cancer live and receive care on racial treatment inequities.

Noah Hammarlund, Sarah K Holt, Ruth Etzioni, Danté Morehead, Jenney R Lee, Erika M Wolff, Yohali Burrola-Mendez, Liz Sage, John L Gore, Yaw A Nyame

Erratum issuedAbstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Noah HammarlundDepartment of Health Services Research Management & Policy, University of Florida, Gainesville, FL, United States.ORCID 0000-0002-3446-2700
Sarah K HoltDepartment of Urology, University of Washington Medical Center, Seattle, WA, United States.ORCID 0000-0001-6302-5502
Ruth EtzioniDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID 0000-0002-9164-6370
Danté MoreheadDepartment of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA, United States.ORCID 0009-0003-3648-7754
Jenney R LeeDepartment of Urology, University of Washington Medical Center, Seattle, WA, United States.ORCID 0000-0003-4667-6148
Erika M WolffDepartment of Urology, University of Washington Medical Center, Seattle, WA, United States.ORCID 0000-0003-1160-374X
Yohali Burrola-MendezDepartment of Urology, University of Washington Medical Center, Seattle, WA, United States.ORCID 0000-0001-9357-7543
Liz SageDepartment of Urology, University of Washington Medical Center, Seattle, WA, United States.ORCID 0000-0003-1700-7113
John L GoreDepartment of Urology, University of Washington Medical Center, Seattle, WA, United States.ORCID 0000-0002-2847-5062
Yaw A NyameDepartment of Urology, University of Washington Medical Center, Seattle, WA, United States.ORCID 0000-0002-8799-6749

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RUTH D ETZIONI · 2002 to 2026
$58.1M
Andy Hill Cancer Research EndowmentCancer Research EndowmentDepartment of DefenseNCI NIH HHS P50 CA097186NIH HHSSpecialized Program of Research Excellence P50 CA097186-17
6 · The paper itself

Abstract

backgroundBlack individuals are less likely to be treated for prostate cancer even though they are more than twice as likely to die compared with White individuals. The complex causes of these inequities are influenced by social and structural factors, including racism, which contribute to the differential delivery of care. This study investigates how factors related to the location of where individuals live and receive care affect treatment inequities for prostate cancer between Black and White individuals. We hypothesize that both location and race independently influence treatment inequities.

methodsWe used data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry linked to Medicare claims to estimate the treatment inequity, as defined by differences in radiation or radical prostatectomy. Fixed effects at the physician, hospital, and patient ZIP code levels were incorporated to adjust for all time-invariant factors at these levels.

resultsThe results indicate that residential location-related factors explain only half of the treatment inequity, whereas provider- and hospital-level factors do not significantly account for disparities. Even after accounting for all time-invariant factors, significant differences in treatment rates persist.

conclusionsThe study highlights the importance of understanding race as a social construct and racism as a systemic and structural phenomenon in addressing treatment inequities. These findings provide a necessary step toward understanding equitable care and designing interventions to solve this inequity.

Indexed as

Black or African AmericanHealthcare DisparitiesProstatic NeoplasmsRacismWhiteAgedAged, 80 and overHumansMaleMedicareProstatectomySEER ProgramUnited States

Identifiers

PMID39565920
PMCPMC11972675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.